全球體外膜氧合（體外膜氧合）插管市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計體外膜氧合（ECMO）插管市場將從 2025 年的 4,036 萬美元成長到 2034 年的 6,256 萬美元，2026 年至 2034 年的複合年成長率為 4.99%。

隨著體外膜氧合（ECMO）療法在治療嚴重心臟衰竭衰竭的重要性日益凸顯，全球ECMO插管市場正穩定成長。 ECMO插管是體外生命維持過程中用於體外循環血液的關鍵組件。急性呼吸窘迫症候群和嚴重心臟併發症等嚴重的日益增多，推動了對ECMO系統及相關組件的需求。

重症監護技術的進步和體外膜氧合（ECMO）手術流程的改進也推動了市場成長。現代ECMO插管的設計旨在最大限度地提高血流效率，同時最大限度地減少治療過程中的併發症。醫院和專科加護病房擴大採用ECMO系統來處理複雜病例。此外，醫護人員對ECMO的認知與訓練的提高也提高了ECMO治療的成功率。

隨著醫療系統加大對先進生命支持技術的投入，市場預計將會成長。體外膜氧合（ECMO）設備的研究和創新將帶來改進的插管設計和更安全的治療流程。隨著全球重症監護基礎設施的擴展和對先進呼吸支援需求的成長，ECMO插管仍將是挽救生命治療的重要組成部分。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球體外膜氧合（ECMO）插管市場：依類型分類

• 市場分析、洞察與預測
• 靜脈-動脈型
• 靜脈-靜脈
• 動靜脈型

第5章 全球體外膜氧合（ECMO）插管市場：依病患類型分類

• 市場分析、洞察與預測
• 新生
• 兒童
• 成人

第6章 全球體外膜氧合插管市場：依應用分類

• 市場分析、洞察與預測
• 呼吸系統
• 心
• ECPR

第7章 全球體外膜氧合（ECMO）插管市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 門診手術中心
• 其他

第8章 全球體外膜氧合（ECMO）插管市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Medtronic
  • LivaNova PLC
  • Edwards Lifesciences Corporation
  • Getinge
  • Andocor
  • Changzhou KangXin Medical Instruments Co. Ltd
  • Free Life Medical GmbH
  • Fresenius Medical Care AG
  • Abbott

The Extracorporeal Membrane Oxygenation Cannula Market size is expected to reach USD 62.56 Million in 2034 from USD 40.36 Million (2025) growing at a CAGR of 4.99% during 2026-2034.

The global extracorporeal membrane oxygenation cannula market is growing steadily as ECMO therapy becomes increasingly important in the treatment of severe cardiac and respiratory failure. ECMO cannulas are essential components used to circulate blood outside the body during extracorporeal life support procedures. The rising prevalence of critical conditions such as acute respiratory distress syndrome and severe cardiac complications is driving demand for ECMO systems and associated components.

Advancements in critical care technologies and improvements in ECMO procedures are also supporting market growth. Modern ECMO cannulas are designed to enhance blood flow efficiency while minimizing complications during treatment. Hospitals and specialized intensive care units are increasingly adopting ECMO systems to manage complex medical cases. Additionally, increased awareness and training among healthcare professionals are improving the success rates of ECMO therapy.

In the future, the market is expected to grow as healthcare systems invest in advanced life-support technologies. Research and innovation in ECMO equipment will lead to improved cannula designs and safer treatment procedures. As critical care infrastructure expands globally and the demand for advanced respiratory support increases, ECMO cannulas will remain an essential component of life-saving therapies.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Veno-Arterial
• Veno-Venous
• Arterio-Venous

By Patient Type

• Neonates
• Pediatric
• Adult

By Application

• Respiratory
• Cardiac
• ECPR

By End Use

• Hospitals
• Ambulatory Surgical Centers
• Others

COMPANIES PROFILED

• Medtronic, LivaNova PLC, Edwards Lifesciences Corporation, Getinge, Andocor, Changzhou KangXin Medical Instruments Co Ltd, Free Life Medical GmbH, Fresenius Medical Care AG, Abbott
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION CANNULA MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Veno-Arterial Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Veno-Venous Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Arterio-Venous Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION CANNULA MARKET: BY PATIENT TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Patient Type
• 5.2. Neonates Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION CANNULA MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Respiratory Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cardiac Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. ECPR Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION CANNULA MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION CANNULA MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Type
  • 8.2.2 By Patient Type
  • 8.2.3 By Application
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Type
  • 8.3.2 By Patient Type
  • 8.3.3 By Application
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Type
  • 8.4.2 By Patient Type
  • 8.4.3 By Application
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Type
  • 8.5.2 By Patient Type
  • 8.5.3 By Application
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Type
  • 8.6.2 By Patient Type
  • 8.6.3 By Application
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION CANNULA INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Medtronic
  • 10.2.2 LivaNova PLC
  • 10.2.3 Edwards Lifesciences Corporation
  • 10.2.4 Getinge
  • 10.2.5 Andocor
  • 10.2.6 Changzhou KangXin Medical Instruments Co. Ltd
  • 10.2.7 Free Life Medical GmbH
  • 10.2.8 Fresenius Medical Care AG
  • 10.2.9 Abbott